Medibio Limited Stock Price Prediction

Intrinsic Valuation Low Real High 0.00 0.02 4.48 Details

Naive Forecast Low Next High 0.0003 0.02 4.47 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.02 0.02 0.02 Details

Medibio After-Hype Price Prediction Density Analysis

Medibio Estimiated After-Hype Price Volatility

Medibio Pink Sheet Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.56	4.46	0.00	0.00	0 Events / Month	0 Events / Month	Uncertain

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
0.02	0.02	27.39	0.00   Notes

Medibio Hype Timeline

Medibio Limited is now traded for 0.02. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medibio is forecasted to increase in value after the next headline, with the price projected to jump to 0.02 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is estimated to be 27.39%, whereas the daily expected return is now at -0.56%. The volatility of related hype on Medibio is about 0.0%, with the expected price after the next announcement by competition of 0.02. Medibio Limited has accumulated 66.42 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Medibio Limited has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Medibio until it has trouble settling it off, either with new capital or with free cash flow. So, Medibio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medibio Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medibio to invest in growth at high rates of return. When we think about Medibio's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Medibio Basic Forecasting Models to cross-verify your projections.

Medibio Related Hype Analysis

Medibio Additional Predictive Modules

Most predictive techniques to examine Medibio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medibio using various technical indicators. When you analyze Medibio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Medibio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medibio Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medibio based on analysis of Medibio hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Medibio depends on current market conditions and Medibio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medibio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medibio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

When running Medibio's price analysis, check to measure Medibio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibio is operating at the current time. Most of Medibio's value examination focuses on studying past and present price action to predict the probability of Medibio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibio's price. Additionally, you may evaluate how the addition of Medibio to your portfolios can decrease your overall portfolio volatility.